Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Immunome, Inc. is a biopharmaceutical company focused on developing targeted cancer therapies, including antibody-drug conjugates (ADCs), radioligand therapies, and small molecules. Its pipeline features clinical and preclinical assets targeting solid tumors, hematologic malignancies, and novel cancer markers like ROR1 and FAP. The company leverages proprietary payloads, innovative targets, and strategic collaborations to address unmet medical needs in oncology.
This description was generated via AI from an annual report. Updated about 1 year ago.